These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 2785605

  • 1. Phase I study of an anti-breast cancer immunotoxin by continuous infusion: report of a targeted toxic effect not predicted by animal studies.
    Gould BJ, Borowitz MJ, Groves ES, Carter PW, Anthony D, Weiner LM, Frankel AE.
    J Natl Cancer Inst; 1989 May 10; 81(10):775-81. PubMed ID: 2785605
    [Abstract] [Full Text] [Related]

  • 2. Phase I evaluation of an anti-breast carcinoma monoclonal antibody 260F9-recombinant ricin A chain immunoconjugate.
    Weiner LM, O'Dwyer J, Kitson J, Comis RL, Frankel AE, Bauer RJ, Konrad MS, Groves ES.
    Cancer Res; 1989 Jul 15; 49(14):4062-7. PubMed ID: 2786751
    [Abstract] [Full Text] [Related]

  • 3. Therapy of patients with T-cell lymphomas and leukemias using an anti-CD7 monoclonal antibody-ricin A chain immunotoxin.
    Frankel AE, Laver JH, Willingham MC, Burns LJ, Kersey JH, Vallera DA.
    Leuk Lymphoma; 1997 Jul 15; 26(3-4):287-98. PubMed ID: 9322891
    [Abstract] [Full Text] [Related]

  • 4. Immunotoxin therapy of small-cell lung cancer: a phase I study of N901-blocked ricin.
    Lynch TJ, Lambert JM, Coral F, Shefner J, Wen P, Blattler WA, Collinson AR, Ariniello PD, Braman G, Cook S, Esseltine D, Elias A, Skarin A, Ritz J.
    J Clin Oncol; 1997 Feb 15; 15(2):723-34. PubMed ID: 9053498
    [Abstract] [Full Text] [Related]

  • 5. Phase I trial of H65-RTA immunoconjugate in patients with cutaneous T-cell lymphoma.
    LeMaistre CF, Rosen S, Frankel A, Kornfeld S, Saria E, Meneghetti C, Drajesk J, Fishwild D, Scannon P, Byers V.
    Blood; 1991 Sep 01; 78(5):1173-82. PubMed ID: 1878584
    [Abstract] [Full Text] [Related]

  • 6. Phase I study of monoclonal antibody-ricin A chain immunotoxin XomaZyme-791 in patients with metastatic colon cancer.
    Byers VS, Rodvien R, Grant K, Durrant LG, Hudson KH, Baldwin RW, Scannon PJ.
    Cancer Res; 1989 Nov 01; 49(21):6153-60. PubMed ID: 2790828
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Phase I study of monoclonal antibody-ricin A chain immunoconjugate Xomazyme-791 in patients with metastatic colon cancer.
    LoRusso PM, Lomen PL, Redman BG, Poplin E, Bander JJ, Valdivieso M.
    Am J Clin Oncol; 1995 Aug 01; 18(4):307-12. PubMed ID: 7625372
    [Abstract] [Full Text] [Related]

  • 12. Therapy of metastatic malignant melanoma using Xomazyme Mel, a murine monoclonal anti-melanoma ricin A chain immunotoxin.
    Spitler LE, Mischak R, Scannon P.
    Int J Rad Appl Instrum B; 1989 Aug 01; 16(6):625-7. PubMed ID: 2606718
    [No Abstract] [Full Text] [Related]

  • 13. Phase I trial of an anti-CD19 deglycosylated ricin A chain immunotoxin in non-Hodgkin's lymphoma: effect of an intensive schedule of administration.
    Conry RM, Khazaeli MB, Saleh MN, Ghetie V, Vitetta ES, Liu T, LoBuglio AF.
    J Immunother Emphasis Tumor Immunol; 1995 Nov 01; 18(4):231-41. PubMed ID: 8680651
    [Abstract] [Full Text] [Related]

  • 14. Anti-B4-blocked ricin: a phase I trial of 7-day continuous infusion in patients with B-cell neoplasms.
    Grossbard ML, Lambert JM, Goldmacher VS, Spector NL, Kinsella J, Eliseo L, Coral F, Taylor JA, Blättler WA, Epstein CL.
    J Clin Oncol; 1993 Apr 01; 11(4):726-37. PubMed ID: 7683045
    [Abstract] [Full Text] [Related]

  • 15. A Phase II study of adjuvant therapy with anti-B4-blocked ricin after autologous bone marrow transplantation for patients with relapsed B-cell non-Hodgkin's lymphoma.
    Grossbard ML, Multani PS, Freedman AS, O'Day S, Gribben JG, Rhuda C, Neuberg D, Nadler LM.
    Clin Cancer Res; 1999 Sep 01; 5(9):2392-8. PubMed ID: 10499609
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Monensin in lipid emulsion for the potentiation of ricin A chain immunotoxins.
    Griffin T, Raso V.
    Cancer Res; 1991 Aug 15; 51(16):4316-22. PubMed ID: 1868454
    [Abstract] [Full Text] [Related]

  • 19. Phase I immunotoxin trial in patients with B-cell lymphoma.
    Vitetta ES, Stone M, Amlot P, Fay J, May R, Till M, Newman J, Clark P, Collins R, Cunningham D.
    Cancer Res; 1991 Aug 01; 51(15):4052-8. PubMed ID: 1855219
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of human tumor growth by intraperitoneal immunotoxins in nude mice.
    Marks A, Ettenson D, Bjorn MJ, Lei M, Baumal R.
    Cancer Res; 1990 Jan 15; 50(2):288-92. PubMed ID: 2295069
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.